We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Correction: Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets.
- Authors
Zheng, Fang; Liao, Yi-Ji; Cai, Mu-Yan; Liu, Tian-Hao; Chen, Shu-Peng; Wu, Pei-Hong; Wu, Long; Bian, Xiu-Wu; Guan, Xin-Yuan; Zeng, Yi-Xin; Yuan, Yun-Fei; Kung, Hsiang-Fu; Xie, Dan
- Abstract
(D) The in vivo effects of miR-101 on HCC cell metastasis using an experimental metastasis assay, in which lent-miR-101, control lent-miR-ctr and mock LM9 cells were injected into the tail vein of SCID mice, respectively. Down, ectopic overexpression of miR-101 by lenti-miR-101 reduces the levels of ROCK2 proteins in LM9 cells, as compared to that in both MOCK and lent-miR-ctr treated LM9 cells. Down, ectopic overexpression of miR-101 by lenti-miR-101 reduces the levels of I STMN1 i protein in LM9 cells, as compared to that in both Mock and lent-miR-ctr treated LM9 cells.
- Subjects
HEPATOCELLULAR carcinoma; HEMATOXYLIN &; eosin staining; CADHERINS; GENETIC overexpression
- Publication
PLoS Genetics, 2021, Vol 17, Issue 12, p1
- ISSN
1553-7390
- Publication type
Correction Notice
- DOI
10.1371/journal.pgen.1009960